Insulin and oral hypoglycaemic agents. II. Clinical and therapeutic aspects.
D000284:Administration, Oral; D000328:Adult; D001645:Biguanides / Q000009:adverse effects; D001786:Blood Glucose / Q000032:analysis; D003327:Coronary Disease / Q000209:etiology; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000188:drug therapy; D003927:Diet, Diabetic; D005260:Female; D005951:Glucose Tolerance Test; D006029:Glycosuria; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007328:Insulin / Q000009:adverse effects / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000209:etiology; D007677:Kidney Function Tests; D008107:Liver Diseases / Q000209:etiology; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000503:physiopathology; D013453:Sulfonylurea Compounds / Q000009:adverse effects
D001645:Biguanides; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds